8-K
filed June 16, 2023, 7:59 PM ET
ticker LAB
CIK 0001162194
other material
confidence high
sentiment neutral
materiality 0.50
Standard BioTools shareholders approve 4.7M share equity plan increase, elect directors
STANDARD BIOTOOLS INC.
- Equity plan amendment adding 4,700,000 shares approved with 109.6M votes for (11.4M against).
- Class I directors Michael Egholm and Fenel Eloi elected; B-1/B-2 directors Casdin and Madaus elected.
- Advisory say-on-pay vote passed (99.7M for, 21.3M against); board adopts annual frequency.
- PricewaterhouseCoopers ratified as auditor with 139.3M votes for, 233k against.
- Approximately 90.7% of 153.8M total votes were present at the annual meeting.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
STANDARD BIOTOOLS INC. shareholders approved Election of B-1 Director (Series B-1 Preferred Stock).
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
The holders of Series B-1 Preferred Stock, voting separately as a class, voted all shares of Series B-1 Preferred Stock to nominate and elect Eli Casdin to the Company’s board of directors in connection with the Annual Meeting. Nominee Votes For Votes Withheld Eli Casdin 127,780 -
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
STANDARD BIOTOOLS INC. shareholders approved Approval of the Amended and Restated 2011 Equity Incentive Plan.
- Proposal
- equity plan
- Outcome
- passed
Exact text from the filing
The proposal to approve the Company’s Amended and Restated 2011 Equity Incentive Plan to increase the shares of common stock reserved thereunder by 4,700,000 shares was approved by the following vote: Votes For Votes Against Abstentions Broker Non-Votes 109,601,367 11,404,808 458,590 18,071,894
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
STANDARD BIOTOOLS INC. shareholders approved Election of B-2 Director (Series B-2 Preferred Stock).
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
The holders of Series B-2 Preferred Stock, voting separately as a class, voted all shares of Series B-2 Preferred Stock to nominate and elect Martin D. Madaus to the Company’s board of directors in connection with the Annual Meeting. Nominee Votes For Votes Withheld Martin D. Madaus 127,779 -
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
STANDARD BIOTOOLS INC. shareholders approved Advisory Vote on Approval of Executive Compensation at the 2022-12-31 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2022-12-31
Exact text from the filing
The proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers for the year ended December 31, 2022 was approved by the following vote: Votes For Votes Against Abstentions Broker Non-Votes 99,659,482 21,330,720 474,563 18,071,894
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
STANDARD BIOTOOLS INC. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-12-31 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-31
Exact text from the filing
The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 was approved by the following vote: Votes For Votes Against Abstentions 139,270,633 233,343 32,683
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
STANDARD BIOTOOLS INC. shareholders approved Advisory Vote on Frequency of Vote to Approve Executive Compensation (one year).
- Proposal
- say on pay frequency
- Outcome
- passed
Exact text from the filing
The proposal to approve, on an advisory basis, the frequency of the advisory stockholder vote on the compensation of the Company’s named executive officers was ratified as one year by the following vote: Votes For One Year Votes For Two Years Votes For Three Years Abstentions Broker Non-Votes 120,966,667 163,420 221,890 112,788 18,071,894
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
STANDARD BIOTOOLS INC. shareholders approved Election of Class I Directors.
- Proposal
- director election
- Outcome
- passed
Exact text from the filing
The following nominees were elected to serve as Class I directors, to hold office until the Company’s 2026 annual meeting of stockholders or until their respective successors have been duly elected and qualified or their earlier resignation or removal: Nominee Votes For Votes Withheld Broker Non-Votes Michael Egholm, Ph.D. 120,101,799 1,362,966 18,071,894 Fenel M. Eloi 120,414,232 1,050,533 18,071,894
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.